Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
In-Silico docking of HIV-1 integrase inhibitors reveals a novel drug type acting on an enzyme/DNA reaction intermediate.
Savarino A
Retrovirology 2007, 4:21
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.
37%37%


 Research    
Natural variation of HIV-1 group M integrase: Implications for a new class of antiretroviral inhibitors
Rhee SY, Liu TF, Kiuchi M, Zioni R, Gifford RJ, Holmes SP, Shafer RW
Retrovirology 2008, 5:74 (7 August 2008)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles]
2.
37%37%


 Editorial    
Please comment, but with civility
Jeang KT
Retrovirology 2008, 5:35 (24 April 2008)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles] [1 comment]
3.
37%37%


 Research    
Human immunodeficiency virus integrase inhibitors efficiently suppress feline immunodeficiency virus replication in vitro and provide a rationale to redesign antiretroviral treatment for feline AIDS
Savarino A, Pistello M, D'Ostilio D, Zabogli E, Taglia F, Mancini F, Ferro S, Matteucci D, De Luca L, Barreca ML, Ciervo A, Chimirri A, Ciccozzi M, Bendinelli M
Retrovirology 2007, 4:79 (30 October 2007)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles] [1 comment]

This article is also cited by a further 1 article in PubMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2008 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.